MDR1 Mutations and General Anesthesia in Small Animal Patient Elizabeth M. Goudie-DeAngelis, DVM, MS, DACVAA MDR1 mutation is more...

Zenalpha® is a newly approved combination of medetomidine (0.5 mg/mL) and the peripheral alpha-2 antagonist vatinoxan (10 mg/mL),...

Annatasha Bartel DVM DACVAA Dexmedetomidine is a highly selective alpha-2 agonist, often used in veterinary medicine for its excellent...